Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05985655
Title Study to Assess GTAEXS617 in Patients With Advanced Solid Tumors (ELUCIDATE)
Acronym ELUCIDATE
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Exscientia AI Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | BEL


No variant requirements are available.